Impaired cortico-striatal functional connectivity in prodromal Huntington's Disease

Neuroscience Letters

Volumn 514, Issue 2, 2012, Pages 204-209

  Unschuld, Paul G ^a   Joel, Suresh E ^b   Liu, Xinyang ^a   Shanahan, Megan ^a   Margolis, Russell L ^a   Biglan, Kevin M ^c   Bassett, Susan S ^a   Schretlen, David J ^a   Redgrave, Graham W ^a   van Zijl, Peter C M ^a,b   Pekar, James J ^a,b   Ross, Christopher A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KENNEDY KRIEGER INSTITUTE   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Caudate nucleus; FMRI; Functional connectivity; Huntington's Disease; Neurodegeneration; Prodromal phase

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN CORTEX; BRAIN REGION; BRAIN SIZE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUNTINGTON CHOREA; HYPOTHESIS; IMAGE ANALYSIS; MALE; MOTOR COORDINATION; NEUROTRANSMISSION; OXYGEN BLOOD LEVEL; PRIORITY JOURNAL;

ADULT; BRAIN MAPPING; CEREBRAL CORTEX; CORPUS STRIATUM; DISEASE PROGRESSION; FEMALE; FUNCTIONAL NEUROIMAGING; HUMANS; HUNTINGTON DISEASE; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEURAL PATHWAYS;

EID: 84862822287     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.02.095     Document Type: Article

References (48)

1. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci. 1986, 9:357-381.
2. Aylward E.H. Change in MRI striatal volumes as a biomarker in preclinical Huntington's disease. Brain Res. Bull. 2007, 72:152-158.
3. Aylward E.H., Li Q., Stine O.C., Ranen N., Sherr M., Barta P.E., Bylsma F.W., Pearlson G.D., Ross C.A. Longitudinal change in basal ganglia volume in patients with Huntington's disease. Neurology 1997, 48:394-399.
4. Aylward E.H., Nopoulos P.C., Ross C.A., Langbehn D.R., Pierson R.K., Mills J.A., Johnson H.J., Magnotta V.A., Juhl A.R., Paulsen J.S. Longitudinal change in regional brain volumes in prodromal Huntington disease. J. Neurol. Neurosurg. Psychiatry 2010.
5. Aylward E.H., Rosenblatt A., Field K., Yallapragada V., Kieburtz K., McDermott M., Raymond L.A., Almqvist E.W., Hayden M., Ross C.A. Caudate volume as an outcome measure in clinical trials for Huntington's disease: a pilot study. Brain Res. Bull. 2003, 62:137-141.
6. Bazin P.L., Pham D.L. Topology-preserving tissue classification of magnetic resonance brain images. IEEE Trans. Med. Imaging 2007, 26:487-496.
7. Biswal B., Yetkin F.Z., Haughton V.M., Hyde J.S. Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn. Reson. Med. 1995, 34:537-541.
8. Bohanna I., Georgiou-Karistianis N., Egan G.F. Connectivity-based segmentation of the striatum in Huntington's disease: vulnerability of motor pathways. Neurobiol. Dis. 2011, 42:475-481.
9. Brandt J., Bylsma F.W., Gross R., Stine O.C., Ranen N., Ross C.A. Trinucleotide repeat length and clinical progression in Huntington's disease. Neurology 1996, 46:527-531.
10. Buckner R.L., Sepulcre J., Talukdar T., Krienen F.M., Liu H., Hedden T., Andrews-Hanna J.R., Sperling R.A., Johnson K.A. Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease. J. Neurosci. 2009, 29:1860-1873.
11. Cepeda C., Wu N., Andre V.M., Cummings D.M., Levine M.S. The corticostriatal pathway in Huntington's disease. Prog. Neurobiol. 2007, 81:253-271.
12. Damoiseaux J.S., Rombouts S.A., Barkhof F., Scheltens P., Stam C.J., Smith S.M., Beckmann C.F. Consistent resting-state networks across healthy subjects. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:13848-13853.
13. Dumas E.M., van den Bogaard S.J., Ruber M.E., Reilman R.R., Stout J.C., Craufurd D., Hicks S.L., Kennard C., Tabrizi S.J., van Buchem M.A., van der Grond J., Roos R.A. Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease. Hum. Brain Mapp. 2012, 33:203-212.
14. Eidelberg D., Surmeier D.J. Brain networks in Huntington disease. J. Clin. Invest. 2011, 121:484-492.
15. Fisher A.O. Frequency distribution of the values of the correlation coefficient in samples from an indefinitely large population. Biometrika 1915, 10:522-529.
16. Folstein S.E., Jensen B., Leigh R.J., Folstein M.F. The measurement of abnormal movement: methods developed for Huntington's disease. Neurobehav. Toxicol. Teratol. 1983, 5:605-609.
17. Fox M.D., Raichle M.E. Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat. Rev. Neurosci. 2007, 8:700-711.
18. Fox M.D., Snyder A.Z., Vincent J.L., Corbetta M., Van Essen D.C., Raichle M.E. The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:9673-9678.
19. Friston K.J., Frith C.D., Liddle P.F., Frackowiak R.S. Functional connectivity: the principal-component analysis of large (PET) data sets. J. Cereb. Blood Flow Metab. 1993, 13:5-14.
20. Gusella J.F., McNeil S., Persichetti F., Srinidhi J., Novelletto A., Bird E., Faber P., Vonsattel J.P., Myers R.H., MacDonald M.E. Huntington's disease. Cold Spring Harb. Symp. Quant. Biol. 1996, 61:615-626.
21. HD_Collaborative_Research_Group A novel gene containing a trinucleotide-repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 1993, 72:971-983.
22. Holm S. A simple sequentially rejective bonferroni test procedure. Scand. J. Stat. 1979, 6:65-70.
23. Joel D. Open interconnected model of basal ganglia-thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease. Mov. Disord. 2001, 16:407-423.
24. Joel S.E., Caffo B.S., van Zijl P.C., Pekar J.J. On the relationship between seed-based and ICA-based measures of functional connectivity. Magn Reson Med 2011, 66:644-657.
25. Klöppel S., Draganski B., Siebner H.R., Tabrizi S.J., Weiller C., Frackowiak R.S. Functional compensation of motor function in pre-symptomatic Huntington's disease. Brain 2009, 132:1624-1632.
26. Langbehn D.R., Brinkman R.R., Falush D., Paulsen J.S., Hayden M.R. A new model for prediction of the age-of-onset and penetrance for Huntington's disease based on CAG length. Clin. Genet. 2004, 65:267-277.
27. Marder K., Zhao H., Myers R.H., Cudkowicz M., Kayson E., Kieburtz K., Orme C., Paulsen J., Penney J.B., Siemers E., Shoulson I. Rate of functional decline in Huntington's disease. Huntington Study Group. Neurology 2000, 54:452-458.
28. Marrakchi-Kacem L., Delmaire C., Tucholka A., Roca P., Guevara P., Poupon F., Yelnik J., Durr A., Mangin J.F., Lehericy S., Poupon C. Analysis of the striato-thalamo-cortical connectivity on the cortical surface to infer biomarkers of Huntington's disease. Med. Image Comput. Comput. Assist. Interv. 2010, 13:217-224.
29. Mayberg H.S. Limbic-cortical dysregulation: a proposed model of depression. J. Neuropsychiatry Clin. Neurosci. 1997, 9:471-481.
30. Mayberg H.S. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br. Med. Bull. 2003, 65:193-207.
31. Mayberg H.S., Starkstein S.E., Peyser C.E., Brandt J., Dannals R.F., Folstein S.E. Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease. Neurology 1992, 42:1791-1797.
32. Paulsen J.S. Functional imaging in Huntington's disease. Exp. Neurol. 2009, 216:272-277.
33. Paulsen J.S., Magnotta V.A., Mikos A.E., Paulson H.L., Penziner E., Andreasen N.C., Nopoulos P.C. Brain structure in preclinical Huntington's disease. Biol. Psychiatry 2006, 59:57-63.
34. Penney J.B., Vonsattel J.P., MacDonald M.E., Gusella J.F., Myers R.H. CAG repeat number governs the development rate of pathology in Huntington's disease. Ann. Neurol. 1997, 41:689-692.
35. Raichle M.E. Two views of brain function. Trends Cogn. Sci. 2010, 14:180-190.
36. Reading S.A., Dziorny A.C., Peroutka L.A., Schreiber M., Gourley L.M., Yallapragada V., Rosenblatt A., Margolis R.L., Pekar J.J., Pearlson G.D., Aylward E., Brandt J., Bassett S.S., Ross C.A. Functional brain changes in presymptomatic Huntington's disease. Ann. Neurol. 2004, 55:879-883.
37. Reilmann R., Bohlen S., Klopstock T., Bender A., Weindl A., Saemann P., Auer D.P., Ringelstein E.B., Lange H.W. Tongue force analysis assesses motor phenotype in premanifest and symptomatic Huntington's disease. Mov. Disord. 2010, 25:2195-2202.
38. Rosas H.D., Salat D.H., Lee S.Y., Zaleta A.K., Pappu V., Fischl B., Greve D., Hevelone N., Hersch S.M. Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity. Brain 2008, 131:1057-1068.
39. Ross C.A., Tabrizi S.J. Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol 2011, 10:83-98.
40. Talairach J., Tournoux P. A co-planar stereotaxic atlas of a human brain 1988, Georg Thieme Verlag, Thieme, Stuttgart.
41. Thu D.C., Oorschot D.E., Tippett L.J., Nana A.L., Hogg V.M., Synek B.J., Luthi-Carter R., Waldvogel H.J., Faull R.L. Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease. Brain 2010, 133:1094-1110.
42. van de Ven V.G., Formisano E., Prvulovic D., Roeder C.H., Linden D.E. Functional connectivity as revealed by spatial independent-component-analysis of fMRI measurements during rest. Hum. Brain Mapp. 2004, 22:165-178.
43. Van Dijk K.R., Hedden T., Venkataraman A., Evans K.C., Lazar S.W., Buckner R.L. Intrinsic functional connectivity as a tool for human connectomics: theory, properties, and optimization. J. Neurophysiol. 2010, 103:297-321.
44. Vonsattel J.P., DiFiglia M. Huntington disease. J. Neuropathol. Exp. Neurol. 1998, 57:369-384.
45. Walker F.O. Huntington's disease. Lancet 2007, 369:218-228.
46. Wolf R.C., Sambataro F., Vasic N., Schonfeldt-Lecuona C., Ecker D., Landwehrmeyer B. Aberrant connectivity of lateral prefrontal networks in presymptomatic Huntington's disease. Exp. Neurol. 2008, 213:137-144.
47. World_Medical_Association Declaration of Helsinki. Law Med. Health Care 1991, 19:264-265.
48. Zhang D., Raichle M.E. Disease and the brain's dark energy. Nat. Rev. Neurol. 2010, 6:15-28.